Platelet-Activating Factor Antagonists: Current Status in Asthma

ISSN： 1173-8804

Source： BioDrugs, Vol.14, Iss.1, 2000-07, pp. : 21-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melanin-Concentrating Hormone Receptor-1 Antagonists as Antiobesity Therapeutics: Current Status

By Kowalski Timothy J.

BioDrugs, Vol. 21, Iss. 5, 2007-01 ,pp. : 311-321

Adis International

Access to resources Recommend Favorite

Cytokine Antagonists for the Treatment of Asthma: Progress to Date

By >

BioDrugs, Vol. 23, Iss. 4, 2009-08 ,pp. : 241-251

Adis International

Access to resources Recommend Favorite

Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration

By Mousa Shaker A.

BioDrugs, Vol. 24, Iss. 3, 2010-06 ,pp. : 183-194

Adis International

Access to resources Recommend Favorite

Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor: Current Status and Future Challenges in Cancer Therapy

By Hsu Jerry Y. Wakelee Heather A.

BioDrugs, Vol. 23, Iss. 5, 2009-10 ,pp. : 289-304

Adis International

Access to resources Recommend Favorite

The Current Status of Malaria Vaccines

By Stoute J.A. Ballou W.R.

BioDrugs, Vol. 10, Iss. 2, 1998-08 ,pp. : 123-136

Adis International

Access to resources Recommend Favorite